Partial Seizures
📧 Sign up to get email alerts when something new happens for Partial Seizures.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2020-09-22Clinical Trial Update: Safety Study of Rufinamide Given as an add-on Therapy to Treat Patients With Seizures [Phase 3]
A Phase 3 safety study of Rufinamide as add-on therapy for refractory partial seizures has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-04-04Clinical Trial Update: GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures [Phase 2]
A Phase 2 trial evaluating GW273225 as add-on therapy for partial seizures in epilepsy was withdrawn.